Evaluation of the effect of oral verapamil on clinical outcome and angiographic restenosis after percutaneous coronary intervention: the randomized, double-blind, placebo-controlled, multicenter Verapamil Slow-Release for Prevention of Cardiovascular Events After Angioplasty (VESPA) Trial.

Source:http://linkedlifedata.com/resource/pubmed/id/15193674

J. Am. Coll. Cardiol. 2004 Jun 16 43 12 2160-5

Download in:

View as

General Info

PMID
15193674